MRI changes and complement activation correlate with epileptogenicity in a mouse model of temporal lobe epilepsy

Brain Structure and Function

Volumn 219, Issue 2, 2014, Pages 683-706

  Kharatishvili, Irina ^a   Shan, Zuyao Y ^a   She, David T ^a   Foong, Samuel ^a   Kurniawan, Nyoman D ^a   Reutens, David C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Complement; Epilepsy animal models; Epileptogenesis; Hippocampus; Magnetic resonance imaging; Parahippocampal cortex; Spontaneous recurrent seizures; Temporal lobe epilepsy

Indexed keywords

COMPLEMENT COMPONENT C3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; EPILEPTOGENESIS; GLIA; HIPPOCAMPUS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROMODULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; SPIKE; SYNAPSE; TEMPORAL LOBE EPILEPSY;

ANIMALIA; MUS;

ANIMALS; BRAIN; BRAIN MAPPING; CALCIUM-BINDING PROTEINS; COMPLEMENT C3; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; EPILEPSY, TEMPORAL LOBE; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICROFILAMENT PROTEINS; MUSCARINIC AGONISTS; PHOSPHOPYRUVATE HYDRATASE; PILOCARPINE; SCLEROSIS; TIME FACTORS;

EID: 84896044684     PISSN: 18632653     EISSN: 18632661     Source Type: Journal    
DOI: 10.1007/s00429-013-0528-4     Document Type: Article

References (88)

1. Abbott NJ, Khan EU, Rollinson CMS, Reichel A, Janigro D, Dombrowski SM, Dobbie MS, Begley DJ (2002) Drug resistance in epilepsy: the role of the blood-brain barrier. Norvatis Found Symp 243:38-47 discussion 47-53, 180-185
2. Alexander JJ, Anderson AJ, Barnum SR, Stevens B, Tenner AJ (2008) The complement cascade: Yin-Yang in neuroinflammation-neuro-protection and -degeneration. J Neurochem 107(5):1169-1187. doi:10.1111/j.1471-4159.2008.05668. x
3. Aronica E, Boer K, van Vliet EA, Redeker S, Baayen JC, Spliet WGM, van Rijen PC, Troost D, da Silva FHL, Wadman WJ, Gorter JA (2007) Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 26(3):497-511. doi:10.1016/j.nbd.2007.01.015 (Pubitemid 46756320)
4. Barnum SR, Jones JL (1995) Differential regulation of C3 gene expression in human astroglioma cells by interferon-gamma and interleukin-1 beta. Neurosci Lett 197(2):121-124. doi:10.1016/0304-3940(95)11923-k
5. Bernasconi N, Duchesne S, Janke A, Lerch J, Collins DL, Bernasconi A (2004) Whole-brain voxel-based statistical analysis of gray alter and white matter in temporal lobe epilepsy. Neuroimage 23(2):717-723. doi:10.1016/j. neuroimage.2004.06.015 (Pubitemid 39370622)
6. Bonilha L, Kobayashi E, Rorden C, Cendes F, Li LM (2003) Medial temporal lobe atrophy in patients with refractory temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 74(12):1627-1630. doi:10.1136/jnnp.74.12.1627 (Pubitemid 37542050)
7. Bonilha L, Nesland T, Martz GU, Joseph JE, Spampinato MV, Edwards JC, Tabesh A (2012) Medial temporal lobe epilepsy is associated with neuronal fibre loss and paradoxical increase in structural connectivity of limbic structures. J Neurol Neurosurg Psychiatry 83(9):903-909. doi:10.1136/jnnp-2012-302476
8. Borges K, Gearing M, McDermott DL, Smith AB, Almonte AG, Wainer BH, Dingledine R (2003) Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Exp Neurol 182(1):21-34. doi:10.1016/s0014-4886(03)00086-4 (Pubitemid 36776247)
9. Borges K, McDermott D, Irier H, Smith Y, Dingledine R (2006) Degeneration and proliferation of astrocytes in the mouse dentate gyrus after pilocarpine-induced status epilepticus. Exp Neurol 201(2):416-427. doi:10.1016/j.expneurol.2006.04.031 (Pubitemid 44344234)
10. Briellmann RS, Kalnins RM, Berkovic SF, Jackson GD (2002) Hippocampal pathology in refractory temporal lobe epilepsy-T2-weighted signal change reflects dentate gliosis. Neurology 58(2):265-271 (Pubitemid 34084218)
11. Buckmaster PS (2004) Laboratory animal models of temporal lobe epilepsy. Comp Med 54(5):473-485
12. Cavalheiro EA, Santos NF, Priel MR (1996) The pilocarpine model of epilepsy in mice. Epilepsia 37(10):1015-1019. doi:10.1111/j.1528-1157.1996. tb00541.x (Pubitemid 26314964)
13. Chen J, Larionov S, Hoerold N, Ullmann C, Elger CE, Schramm J, Becker AJ (2005) Expression analysis of metabotropic glutamate receptors I and III in mouse strains with different susceptibility to experimental temporal lobe epilepsy. Neurosci Lett 375(3):192-197. doi:10.1016/j.neulet.2004.11.008 (Pubitemid 40202951)
14. Choy M, Cheung KK, Thomas DL, Gadian DG, Lythgoe MF, Scott RC (2010a) Quantitative MRI predicts status epilepticus-induced hippocampal injury in the lithium-pilocarpine rat model. Epilepsy Res 88(2-3):221-230. doi:10.1016/j.eplepsyres.2009.11.013
15. Choy M, Wells JA, Thomas DL, Gadian DG, Scott RC, Lythgoe MF (2010b) Cerebral blood flow changes during pilocarpine-induced status epilepticus activity in the rat hippocampus. Exp Neurol 225(1):196-201. doi:10.1016/j. expneurol.2010.06.015
16. Clemens Z, Janszky J, Clemens M, Szucs A, Halasz P (2005) Factors affecting spiking related to sleep and wake states in temporal lobe epilepsy (TLE). Seizure 14(1):52-57. doi:10.1016/j.seizure.2004.09.003 (Pubitemid 40103957)
17. Curia G, Longo D, Biagini G, Jones RSG, Avoli M (2008) The pilocarpine model of temporal lobe epilepsy. J Neurosci Methods 172(2):143-157. doi:10.1016/j.jneumeth.2008.04.019
18. de Lanerolle NC, Lee T-S, Spencer DD (2010) Astrocytes and Epilepsy. Neurotherapeutics 7(4):424-438
19. Dudek FE, Staley KJ (2011) The time course of acquired epilepsy: implications for therapeutic intervention to suppress epileptogenesis. Neurosci Lett 497(3):240-246. doi:10.1016/j.neulet.2011.03.071
20. Duffy BA, Choy M, Riegler J, Wells JA, Anthony DC, Scott RC, Lythgoe MF (2012) Imaging seizure-induced inflammation using an antibody targeted iron oxide contrast agent. Neuroimage 60(2):1149-1155. doi:10.1016/j.neuroimage.2012. 01.048
21. Eng J (2006) ROC analysis: web-based calculator for ROC curves. Johns Hopkins University http://www.rad.jhmi.edu/jeng/javarad/roc/JROCFITi.html. Accessed Jan 30 2013
22. Engel J Jr (2011) Biomarkers in epilepsy: introduction. Biomarkers Med 5(5):537-544. doi:10.2217/bmm.11.62
23. Engel J, Williamson PD, Wieser HG (2008) Mesial temporal lobe epilepsy with hippocampal sclerosis. In: Engel J, Pedley TA (eds) Epilepsy: a comprehensive textbook, 2nd edn. Lippincott-Raven, Philadelphia, pp 2479-2486
24. Fabene PF, Marzola P, Sbarbati A, Bentivoglio M (2003) Magnetic resonance imaging of changes elicited by status epilepticus in the rat brain: diffusion-weighted and T2-weighted images, regional blood volume maps, and direct correlation with tissue and cell damage. Neuroimage 18(2):375-389. doi:10.1016/s1053-8119(02)00025-3 (Pubitemid 36269147)
25. Fabene PF, Weiczner R, Marzola P, Nicolato E, Calderan L, Andrioli A, Farkas E, Sule Z, Mihaly A, Sbarbati A (2006) Structural and functional MRI following 4-aminopyridine-induced seizures: a comparative imaging and anatomical study. Neurobiol Dis 21(1):80-89. doi:10.1016/j.nbd.2005.06.013 (Pubitemid 41817308)
26. French JA, Williamson PD, Thadani VM, Darcey TM, Mattson RH, Spencer SS, Spencer DD (1993) Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann Neurol 34(6):774-780. doi:10.1002/ana.410340604 (Pubitemid 23357889)
27. Genovese CR, Lazar NA, Nichols T (2002) Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 15(4):870-878. doi:10.1006/nimg.2001.1037 (Pubitemid 34852500)
28. Herman ST (2006) Clinical trials for prevention of epileptogenesis. Epilepsy Res 68(1):35-38. doi:10.1016/j.eplepsyres.2005.09.015
29. Ivens S, Kaufer D, Flores LP, Bechmann I, Zumsteg D, Tomkins O, Seiffert E, Heinemann U, Friedman A (2007) TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 130:535-547. doi:10.1093/brain/awl317 (Pubitemid 46181106)
30. Jackson GD, Berkovic SF, Tress BM, Kalnins RM, Fabinyi GCA, Bladin PF (1990) Hippocampal sclerosis can be reliably detected by magnetic-resonance- imaging. Neurology 40(12):1869-1875
31. Jackson GD, Berkovic SF, Duncan JS, Connelly A (1993) Optimizing the diagnosis of hippocampal sclerosis using MR imaging. Am J Neuroradiol 14(3):753-762 (Pubitemid 23170561)
32. Jamali S, Bartolomei F, Robaglia-Schlupp A, Massacrier A, Peragut JC, Regis J, Dufour H, Ravid R, Roll P, Pereira S, Royer B, Roeckel-Trevisiol N, Fontaine M, Guye M, Boucraut J, Chauvel P, Cau P, Szepetowski P (2006) Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex. Brain 129:625-641. doi:10.1093/brain/awl001 (Pubitemid 43278225)
33. Jamali S, Salzmann A, Perroud N, Ponsole-Lenfant M, Cillario J, Roll P, Roeckel-Trevisiol N, Crespel A, Balzar J, Schlachter K, Gruber-Sedlmayr U, Pataraia E, Baumgartner C, Zimprich A, Zimprich F, Malafosse A, Szepetowski P (2010) Functional variant in complement C3 gene promoter and genetic susceptibility to temporal lobe epilepsy and febrile seizures. PLoS One 5(9):e12740. doi:10.1371/journal.pone.0012740
34. Janszky J, Hoppe M, Clemens Z, Janszky I, Gyimesi C, Schulz R, Ebner A (2005) Spike frequency is dependent on epilepsy duration and seizure frequency in temporal lobe epilepsy. Epileptic Disord 7(4):355-359 (Pubitemid 43059339)
35. Kan AA, de Jager W, de Wit M, Heijnen C, van Zuiden M, Ferrier C, van Rijen P, Gosselaar P, Hessel E, van Nieuwenhuizen O, de Graan PNE (2012) Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines. J Neuroinflammation 9:207. doi:20710.1186/1742-2094-9-207
36. Keller SS, Mackay CE, Barrick TR, Wieshmann UC, Howard MA, Roberts N (2002) Voxel-based morphometric comparison of hippocampal and extrahippocampal abnormalities in patients with left and right hippocampal atrophy. Neuroimage 16(1):23-31. doi:10.1006/nimg.2001.1072 (Pubitemid 34852469)
37. Kharatishvili I, Immonen R, Grohn O, Pitkanen A (2007) Quantitative diffusion MRI of hippocampus as a surrogate marker for posttraumatic epileptogenesis. Brain 130:3155-3168. doi:10.1093/brain/awm268 (Pubitemid 350209080)
38. Krendl R, Lurger S, Baumgartner C (2008) Absolute spike frequency predicts surgical outcome in TLE with unilateral hippocampal atrophy. Neurology 71(6):413-418. doi:10.1212/01.wnl.0000310775.87331.90
39. Kuzniecky RI, Bilir E, Gilliam F, Faught E, Palmer C, Morawetz R, Jackson G (1997) Multimodality MRI in mesial temporal sclerosis: relative sensitivity and specificity. Neurology 49(3):774-778 (Pubitemid 27428021)
40. Lee TS, Mane S, Eid T, Zhao H, Lin A, Guan Z, Kim JH, Schweitzer J, King-Stevens D, Weber P, Spencer SS, Spencer DD, de Lanerolle NC (2007) Gene expression in temporal lobe epilepsy is consistent with increased release of glutamate by astrocytes. Mol Med 13(1-2):1-13. doi:10.2119/2006-00079.Lee (Pubitemid 46786829)
41. Li G, Bauer S, Nowak M, Norwood B, Tackenberg B, Rosenow F, Knake S, Oertel WH, Hamer HM (2011) Cytokines and epilepsy. Seizure 20(3):249-256. doi:10.1016/j.seizure.2010.12.005
42. Libbey JE, Kirkman NJ, Wilcox KS, White HS, Fujinami RS (2010) Role for complement in the development of seizures following acute viral infection. J Virol 84(13):6452-6460. doi:10.1128/jvi.00422-10
43. Lucas SM, Rothwell NJ, Gibson RM (2006) The role of inflammation in CNS injury and disease. Brit J Pharmacol 147:S232-S240. doi:10.1038/sj.bjp.0706400 (Pubitemid 43077281)
44. Marchi N, Oby E, Batra A, Uva L, De Curtis M, Hernandez N, Van Boxel-Dezaire A, Najm I, Janigro D (2007) In vivo and in vitro effects of pilocarpine: relevance to ictogenesis. Epilepsia 48(10):1934-1946. doi:10.1111/j.1528-1167.2007.01185.x (Pubitemid 47537452)
45. Marchi N, Fan Q, Ghosh C, Fazio V, Bertolini F, Betto G, Batra A, Carlton E, Najm I, Granata T, Janigro D (2009) Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis 33(2):171-181. doi:10.1016/j.nbd.2008.10.002
46. Marchi N, Granata T, Freri E, Ciusani E, Ragona F, Puvenna V, Teng Q, Alexopolous A, Janigro D (2011) Efficacy of anti-Inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics. PLoS One 6(3):e18200. doi:10.1371/journal.pone.0018200
47. Mathern GW, Babb TL, Vickrey BG, Melendez M, Pretorius JK (1995) The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain 118:105-118. doi:10.1093/brain/118.1.105
48. Mazzuferi M, Kumar G, Rospo C, Kaminski RM (2012) Rapid epileptogenesis in the mouse pilocarpine model: video-EEG, pharmacokinetic and histopathological characterization. Exp Neurol 238(2):156-167. doi:10.1016/j.expneurol.2012.08. 022
49. McDonald CR, Hagler DJ Jr, Ahmadi ME, Tecoma E, Iragui V, Gharapetian L, Dale AM, Halgren E (2008) Regional neocortical thinning in mesial temporal lobe epilepsy. Epilepsia 49(5):794-803. doi:10.1111/j.1528-1167.2008.01539.x (Pubitemid 351652438)
50. Mueller CJ, Bankstahl M, Groeticke I, Loescher W (2009) Pilocarpine vs. lithium-pilocarpine for induction of status epilepticus in mice: development of spontaneous seizures, behavioral alterations and neuronal damage. Eur J Pharmacol 619(1-3):15-24. doi:10.1016/j.ejphar.2009.07.020
51. Nakasu Y, Nakasu S, Morikawa S, Uemura S, Inubushi T, Handa J (1995) Diffusion-weighted MR in experimental sustained seizures elicited with kainic acid. Am J Neuroradiol 16(6):1185-1192
52. Nehlig A (2011) Hippocampal MRI and other structural biomarkers: experimental approach to epileptogenesis. Biomarkers Med 5(5):585-597. doi:10.2217/bmm.11.65
53. Parekh MB, Carney PR, Sepulveda H, Norman W, King M, Mareci TH (2010) Early MR diffusion and relaxation changes in the parahippocampal gyrus precede the onset of spontaneous seizures in an animal model of chronic limbic epilepsy. Exp Neurol 224(1):258-270. doi:10.1016/j.expneurol.2010.03.031
54. Paxinos G, Franklin KBJ (2001) The mouse brain In stereotaxic coordinates. Academic Press, New York
55. Pell GS, Briellmann RS, Waites AB, Abbott DF, Jackson GD (2004) Voxel-based relaxometry: a new approach for analysis of T2 relaxometry changes in epilepsy. Neuroimage 21(2):707-713. doi:10.1016/j.neuroimage.2003.09.059 (Pubitemid 38229933)
56. Pitkanen A (2010) Therapeutic approaches to epileptogenesis-Hope on the horizon. Epilepsia 51:2-17. doi:10.1111/j.1528-1167.2010.02602.x
57. Pitkanen A, Lukasiuk K (2011) Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 10(2):173-186. doi:10.1016/s1474-4422(10) 70310-0
58. Racine RJ (1972) Modification of seizure activity by electrical stimulation.2. Motor seizure. Electroencephalogr Clin Neurophysiol 32(3):281-294. doi:10.1016/0013-4694(72)90177-0
59. Rakhade SN, Shah AK, Agarwal R, Yao B, Asano E, Loeb JA (2007) Activity-dependent gene expression correlates with interictal spiking in human neocortical epilepsy. Epilepsia 48:86-95. doi:10.1111/j.1528-1167.2007.01294.x (Pubitemid 47512207)
60. Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A (2008) Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29(1):142-160. doi:10.1016/j.nbd.2007.08.012 (Pubitemid 350180489)
61. Riazi K, Galic MA, Pittman QJ (2010) Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res 89(1):34-42. doi:10.1016/j.eplepsyres.2009.09.004
62. Roch C, Leroy C, Nehlig A, Namer IJ (2002a) Magnetic resonance imaging in the study of the lithium-pilocarpine model of temporal lobe epilepsy in adult rats. Epilepsia 43(4):325-335. doi:10.1046/j.1528-1157.2002.11301.x (Pubitemid 34297169)
63. Roch C, Leroy C, Nehlig A, Namer IJ (2002b) Predictive value of cortical injury for the development of temporal lobe epilepsy in 21-day-old rats: an MRI approach using the lithium-pilocarpine model. Epilepsia 43(10):1129-1136. doi:10.1046/j.1528-1157.2002.17802.x (Pubitemid 35176117)
64. Rosati A, Aghakhani Y, Bernasconi A, Olivier A, Andermarm F, Gotman J, Dubeau F (2003) Intractable temporal lobe epilepsy with rare spikes is less severe than with frequent spikes. Neurology 60(8):1290-1295 (Pubitemid 36460984)
65. Seiffert E, Dreier JP, Ivens S, Bechmann I, Tomkins O, Heinemann U, Friedman A (2004) Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci 24(36):7829-7836. doi:10.1523/jneurosci.1751-04.2004 (Pubitemid 39215686)
66. Shan ZY, Ji Q, Gajjar A, Reddick WE (2005) A knowledge-guided active contour method of segmentation of cerebella on MR images of pediatric patients with medulloblastoma. J Magn Reson Im 21(1):1-11. doi:10.1002/jmri.20229 (Pubitemid 40041414)
67. Sharma AK, Reams RY, Jordan WH, Miller MA, Thacker HL, Snyder PW (2007) Mesial temporal lobe epilepsy: pathogenesis, induced rodent models and lesions. Toxicol Pathol 35(7):984-999. doi:10.1080/01926230701748305
68. Shibley H, Smith BN (2002) Pilocarpine-induced status epilepticus results in mossy fiber sprouting and spontaneous seizures in C57BL/6 and CD-1 mice. Epilepsy Res 49(2):109-120. doi:10.1016/s0920-1211(02)00012-8 (Pubitemid 34607359)
69. Sloviter RS, Bumanglag AV (2012) Defining "epileptogenesis" and identifying "antiepileptogenic targets" in animal models of acquired temporal lobe epilepsy is not as simple as it might seem. Neuropharmacology. doi:10.1016/j.neuropharm.2012.01.022
70. Steiner B, Kronenberg G, Jessberger S, Brandt MD, Reuter K, Kempermann G (2004) Differential regulation of gliogenesis in the context of adult hippocampal neurogenesis in mice. Glia 46(1):41-52. doi:10.1002/glia.10337 (Pubitemid 38461722)
71. Tomkins O, Friedman O, Ivens S, Reiffurth C, Major S, Dreier JP, Heinemann U, Friedman A (2007) Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex. Neurobiol Dis 25(2):367-377. doi:10.1016/j.nbd.2006.10.006 (Pubitemid 46124017)
72. Ullmann JFP, Keller MD, Watson C, Janke AL, Kurniawan ND, Yang Z, Richards K, Paxinos G, Egan GF, Petrou S, Bartlett P, Galloway GJ, Reutens DC (2012) Segmentation of the C57BL/6J mouse cerebellum in magnetic resonance images. Neuroimage 62(3):1408-1414. doi:10.1016/j.neuroimage.2012.05.061
73. Uva L, Librizzi L, Marchi N, Noe F, Bongiovanni R, Vezzani A, Janigro D, De Curtis M (2008) Acute induction of epileptiform discharges by pilocarpine in the in vitro isolated guinea-pig brain requires enhancement of blood-brain barrier permeability. Neuroscience 151(1):303-312. doi:10.1016/j.neuroscience. 2007.10.037
74. van Gassen KLI, de Wit M, Koerkamp MJAG, Rensen MGA, van Rijen PC, Holstege FCP, Lindhout D, de Graan PNE (2008) Possible role of the innate immunity in temporal lobe epilepsy. Epilepsia 49(6):1055-1065. doi:10.1111/j.1528-1167.2007.01470.x (Pubitemid 351793991)
75. VanLandingham KE, Heinz ER, Cavazos JE, Lewis DV (1998) Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions. Ann Neurol 43(4):413-426. doi:10.1002/ana.410430403 (Pubitemid 28231715)
76. Verkhratsky A, Sofroniew MV, Messing A, deLanerolle NC, Rempe D, Julio Rodriguez J, Nedergaard M (2012) Neurological diseases as primary gliopathies: a reassessment of neurocentrism. Asn Neuro 4 (3). doi:10.1042/an20120010
77. Vezzani A, Granata T (2005) Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46(11):1724-1743. doi:10.1111/j.1528-1167.2005. 00298.x (Pubitemid 44921957)
78. Vezzani A, Balosso S, Ravizza T (2008a) The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 22(6):797-803. doi:10.1016/j.bbi.2008.03.009
79. Vezzani A, Ravizza T, Balosso S, Aronica E (2008b) Glia as a source of cytokines: implications for neuronal excitability and survival. Epilepsia 49:24-32. doi:10.1111/j.1528-1167.2008.01490.x (Pubitemid 351143763)
80. Vezzani A, Aronica E, Mazarati A, Pittman QJ (2011a) Epilepsy and brain inflammation. Exp Neurol. doi:10.1016/j.expneurol.2011.09.033
81. Vezzani A, French J, Bartfai T, Baram TZ (2011b) The role of inflammation in epilepsy. Nat Rev Neurol 7(1):31-40. doi:10.1038/nrneurol.2010.178
82. Vezzani A, Maroso M, Balosso S, Sanchez M-A, Bartfai T (2011c) IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 25(7):1281-1289. doi:10.1016/j.bbi.2011.03.018
83. Wall CJ, Kendall EJ, Obenaus A (2000) Rapid alterations in diffusion-weighted images with anatomic correlates in a rodent model of status epilepticus. Am J Neuroradiol 21(10):1841-1852
84. Wang Y, Majors A, Najm I, Xue M, Comair Y, Modic M, Ng TC (1996) Postictal alteration of sodium content and apparent diffusion coefficient in epileptic rat brain induced by kainic acid. Epilepsia 37(10):1000-1006. doi:10.1111/j.1528-1157.1996.tb00539.x (Pubitemid 26314962)
85. Weissberg I, Reichert A, Heinemann U, Friedman A (2011) Bloodbrain barrier dysfunction in epileptogenesis of the temporal lobe. Epilepsy Res Treat 2011:143908. doi:10.1155/2011/143908
86. White HS (2002) Animal models of epileptogenesis. Neurology 59(9):S7-S14
87. Winawer MR, Makarenko N, McCloskey DP, Hintz TM, Nair N, Palmer AA, Scharfman HE (2007) Acute and chronic responses to the convulsant pilocarpine in DBA/2J and A/J mice. Neuroscience 149(2):465-475. doi:10.1016/j.neuroscience. 2007.06.009 (Pubitemid 47576536)
88. Wuerfel E, Infante-Duarte C, Glumm R, Wuerfel JT (2010) Gadofluorine M-enhanced MRI shows involvement of circumventricular organs in neuroinflammation. J Neuroinflammation 7. doi:10.1186/1742-2094-7-70